Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
chlorhexidine + cymenol
- Development stage
- Phase 1
- Modality
- Small Molecules
- Administration
- Topical, Dental
01
Overview
Chlorhexidine + cymenol is an antiseptic combination used primarily in dental applications. It combines chlorhexidine, a well-established antiseptic agent, with cymenol (o-cymen-5-ol), which has antimicrobial properties against bacteria and fungi. This combination is formulated as both mouthwash and gel preparations for the treatment of gingivitis and periodontitis. Clinical studies have shown that it demonstrates potent and immediate antimicrobial activity on salivary flora and dental plaque biofilm, with effects lasting up to seven hours after application[1][2].
Beyond the preview
Go deeper on chlorhexidine + cymenol.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on chlorhexidine + cymenol.